Losartan and Application site irritation - a phase IV clinical study of FDA data

Summary:

Application site irritation is reported as a side effect among people who take Losartan (losartan potassium), especially for people who are female, 60+ old, also take Amlodipine, and have Hair loss.

The phase IV clinical study analyzes which people have Application site irritation when taking Losartan. It is created by eHealthMe based on reports of 170,768 people who have side effects when taking Losartan from the FDA, and is updated regularly.

What is Losartan?

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,686 Losartan users. Check the latest studies of Losartan.

What is Application site irritation?

Application site irritation is found to be associated with 392 drugs and 698 conditions by eHealthMe. Check the latest studies of Application site irritation.

On Jul, 14, 2026

170,768 people reported to have side effects when taking Losartan.
Among them, 62 people (0.04%) have Application site irritation.

Could Losartan cause Application site irritation?

Among these 62 people:

What is the gender of people who have Application site irritation when taking Losartan? *

female: 63.33 %
male: 36.67 %

What is the age of people who have Application site irritation when taking Losartan? *

What are other drugs people take besides Losartan? *

What are other side effects people have besides Application site irritation? *

Application Site Pruritus (application site severe itching of the skin): 20 people, 32.26%
Application Site Erythema (redness of the skin at application site): 20 people, 32.26%
Application Site Pain: 18 people, 29.03%
Application Site Burn: 8 people, 12.90%
Application Site Discoloration: 6 people, 9.68%
Application Site Inflammation: 6 people, 9.68%
Drug Ineffective: 6 people, 9.68%
Application Site Papules (solid elevation of skin with no visible fluid at application site): 5 people, 8.06%
Application Site Discomfort: 5 people, 8.06%
Application Site Exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface): 5 people, 8.06%

What are the existing conditions these people have? *

Hair Loss: 11 people, 17.74%
High Blood Cholesterol: 9 people, 14.52%
Pain: 5 people, 8.06%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.45%
Insomnia (sleeplessness): 4 people, 6.45%
Parkinson's Disease: 4 people, 6.45%
Back Pain: 3 people, 4.84%
Diabetes: 3 people, 4.84%
Migraine (headache): 3 people, 4.84%
Cardiac Disorder: 3 people, 4.84%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan and have Application site irritation?

- Check whether Application site irritation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Losartan:

Losartan (177,686 reports)

Browse all side effects of Losartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Application site irritation:

Application site irritation (392 drugs)

Browse all the conditions that are associated with Application site irritation:

Application site irritation (698 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan) and Losartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.